The Impact of Locoregional Therapy in Nonmetastatic Inflammatory Breast Cancer: A Population-Based Study

The Impact of Locoregional Therapy in Nonmetastatic Inflammatory Breast Cancer: A Population-Based Study

Background. Inflammatory breast cancer (IBC) is a rare but most aggressive breast cancer subtype. The impact of locoregional therapy on survival in IBC is controversial. Methods. Patients with nonmetastatic IBC between 1988 and 2013 were identified in the Surveillance, Epidemiology, and End Results...

Full description

Bibliographic Details
Main Authors:	Mahvish Muzaffar, Helen M. Johnson, Nasreen A. Vohra, Darla Liles, Jan H. Wong
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	International Journal of Breast Cancer
Online Access:	http://dx.doi.org/10.1155/2018/6438635

Similar Items

Prognostic impact of the pretreatment albumin to alkaline phosphatase ratio for nonmetastatic breast cancer patients
by: Long ZQ, et al.
Published: (2019-05-01)

Locoregional therapy in de novo metastatic breast cancer. The unanswered question
by: Maria-Joao Cardoso, et al.
Published: (2021-08-01)

Reirradiation for Locoregional Recurrent Breast Cancer
by: Sayeh Fattahi, BS, et al.
Published: (2021-01-01)

Impact of breast magnetic resonance imaging on the locoregional staging and management of breast cancer
by: Luciana Karla Lira França, et al.

Proton Reirradiation for Locoregionally Recurrent Breast Cancer
by: Michael J. LaRiviere, MD, et al.
Published: (2021-07-01)

The prognostic value of clinical and pathologic features in nonmetastatic operable male breast cancer
by: Bo Sun, et al.
Published: (2016-01-01)

Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy
by: Kirsten Steinauer, et al.
Published: (2014-05-01)

Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis
by: Daniel Reinhorn, et al.
Published: (2021-08-01)

Impact of serious mental illness on the treatment and mortality of older patients with locoregional high‐grade (nonmetastatic) prostate cancer: retrospective cohort analysis of 49 985 SEER‐Medicare patients diagnosed between 2006 and 2013
by: Dennis A. Fried, et al.
Published: (2019-05-01)

Predictors for locoregional recurrent breast cancer in Egyptian females
by: Ahmed Abdellatif Abdelkader, et al.
Published: (2018-12-01)

Risk Factors of the Invasive Breast Cancer Locoregional Recurrence
by: R. V. Liubota, et al.
Published: (2015-01-01)

Body Composition Analysis of 10 Years versus 5 Years of Adjuvant Endocrine Therapy in Patients with Nonmetastatic Breast Cancer
by: Ruyi Hu, et al.
Published: (2021-01-01)

Circulating Tumor Cells and Cancer Stem Cells: Clinical Implications in Nonmetastatic Breast Cancer
by: M. Sayed, et al.
Published: (2016-11-01)

Circulating Tumor Cells and Cancer Stem Cells: Clinical Implications in Nonmetastatic Breast Cancer
by: M. Sayed, et al.
Published: (2016-01-01)

Vascular Differences Detected by MRI for Metastatic Versus Nonmetastatic Breast and Prostate Cancer Xenografts
by: Zaver M. Bhujwalla, et al.
Published: (2001-01-01)

Regulatory Analysis of Vimentin Expression in Metastatic Versus Nonmetastatic Breast Cancer Cell Lines
by: Bird, Danielle N.
Published: (1994)

Factors associated with cognitive impairment during the first year of treatment for nonmetastatic breast cancer
by: Nicole Rodriguez, et al.
Published: (2021-02-01)

Androgen Deprivation Therapy and Cardiovascular Risk in Chinese Patients with Nonmetastatic Carcinoma of Prostate
by: Gang Huang, et al.
Published: (2014-01-01)

The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer
by: Joshua D. Gruhl, et al.
Published: (2020-03-01)

Transcatheter Arterial Chemoembolization Is a Feasible Palliative Locoregional Therapy for Breast Cancer Liver Metastases
by: Sung W. Cho, et al.
Published: (2010-01-01)

Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer
by: Gang Cai, et al.
Published: (2019-07-01)

Current Role of Chemotherapy in Nonmetastatic Nasopharyngeal Cancer
by: Tapesh Bhattacharyya, et al.
Published: (2018-01-01)

Predictive Nomogram of Subsequent Liver Metastasis After Mastectomy or Breast-Conserving Surgery in Patients With Nonmetastatic Breast Cancer
by: Anli Yang, et al.
Published: (2021-02-01)

MRI assessment of hepatocellular carcinoma after locoregional therapy
by: Rasha S. Hussein, et al.
Published: (2019-01-01)

Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States
by: Omar Abdel-Rahman, MD, et al.
Published: (2018-10-01)

Budget impact analysis of darolutamide for treatment of nonmetastatic castration-resistant prostate cancer
by: Appukkuttan, S., et al.
Published: (2021)

Survival after locoregional recurrence or second primary breast cancer: impact of the disease-free interval.
by: Annemieke Witteveen, et al.
Published: (2015-01-01)

Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence in Johannesburg, South Africa
by: Ruff P, et al.
Published: (2018-02-01)

Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy
by: Jian Xue, et al.
Published: (2021-08-01)

Outcomes Following Salvage Radiation and Systemic Therapy for Isolated Locoregional Recurrence of Breast Cancer after Mastectomy: Impact of Constructed Biologic Subtype
by: Xiaofang Wang, et al.
Published: (2018-01-01)

A Diagnostic Analysis Workflow to Optimal Multiple Tumor Markers to Predict the Nonmetastatic Breast Cancer from Breast Lumps
by: Nan Jiang, et al.
Published: (2021-01-01)

Role of Locoregional Treatment in De Novo Stage IV Breast Cancer
by: Joanna S Lee, et al.
Published: (2020-09-01)

Epigenomic alterations in breast carcinoma from primary tumor to locoregional recurrences.
by: Matahi Moarii, et al.
Published: (2014-01-01)

Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients
by: Khazaeipour Zahra, et al.
Published: (2010-04-01)

Nonmetastatic Ewing’s Sarcoma of the Lumbar Spine in an Adult Patient
by: Maurizio Iacoangeli, et al.
Published: (2012-01-01)

Prognostic Models for Nonmetastatic Triple-Negative Breast Cancer Based on the Pretreatment Serum Tumor Markers with Machine Learning
by: Huihui Chen, et al.
Published: (2021-01-01)

Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer
by: Janssen, H., et al.
Published: (2022)

Postmastectomy radiotherapy and locoregional recurrence rate in high-risk breast cancer patients
by: Šćepanović Danijela S., et al.
Published: (2004-01-01)

Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer
by: Priyanka Narayan, et al.
Published: (2021-06-01)

Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population‐based study
by: Yu Xiao, et al.
Published: (2020-11-01)